Find a Health Care Professional / Researcher

James D. Acton, MD

Title

Director, Cystic Fibrosis Clinic

Appointment

Assistant Professor of Pediatrics

Email

james.acton@chmcc.org

Phone

513-636-6771

Fax

513-636-4615

Credentials

BA: Washington University, St. Louis, MO, 1989.

MD: University of Illinois College of Medicine, Peoria, IL, 1993.

Residency: Pediatrics, St. Louis University/Cardinal Glennon Children's Hospital, St. Louis, MO, 1993-1996.

Chief Resident: Pediatrics, St. Louis University/Cardinal Glennon Children's Hospital, St. Louis, MO, 1996-1997.

Fellowship: Pediatric Pulmonary Medicine, Children's Hospital Medical Center, Cincinnati, OH, 1997-2000.

Certification: Pediatrics, 1996; Pediatric Pulmonology, 2000.

Awards and Honors

Awarded, Best Doctors in America, 2008

Research

Cystic Fibrosis Clinical Outcomes Research, Healthcare Quality Improvement

Research Grants and Contracts

U.S. CF Foundation Therapeutic Development Network, Inc.; A Randomized, Open-label, Multicenter, Phase 3 Trial to Assess the Safety of Tobramycin Inhalation Powder Compared to TOBI in Cystic Fibrosis Subjects; June 2006; Site PI.

U.S. CF Foundation Therapeutic Development Network, Inc.; Antimicrobial Resistance in Sputum Obtained from Patients with Cystic Fibrosis; October 2006; Site PI.

U.S. CF Foundation Therapeutic Development Network, Inc.; Multi-center, Multi-national, Randomized, Placebo-controlled Trial of Azithromycin in Subjects with Cystic Fibrosis 6-18 Years Old, Culture Negative for Pseudomonas aeruginosa; February 2007; Site PI.

U.S. CF Foundation Therapeutic Development Network, Inc.; A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected with Pseudomonas aeruginosa; March 2008; Site PI.

U.S. CF Foundation Therapeutic Development Network, Inc.; Infant Study of Inhaled Saline in Cystic Fibrosis; April 2008; Site PI.

Publications, Most Recent

Acton JD, Kotagal U: Improvements in Healthcare: How can we change the outcome?. J Pediatr. 2005 Sep;147(3):295-301.

Powers SW, Jones JS, Ferguson DS, Piazza-Waggoner C, Daines C, Acton J: Randomized Clinical Trial of Behavioral and Nutrition Treatment to Improve Energy Intake and Growth in Toddlers and Preschoolers with Cystic Fibrosis. Pediatrics. 2005 Dec;116(6):1442-50.

Powers SW, Piazza-Waggoner C, Jones JS, Ferguson KS, Daines C, Acton J: Examining Clinical Trial Results with Single-Subject Analysis: An Example Involving Behavioral and Nutrition Treatment for Young Children with Cystic Fibrosis. J Pediatr Psychol. 2006 Jul;31(6):574-81.

Daftary A, Acton JD, Heubi J, Amin R: Fecal Elastase-1: Utility in pancreatic function in Cystic Fibrosis. J Cyst Fibros. 2006 May;5(2):71-6.

Piazza-Waggoner C, Ferguson KS, Daines C, Acton JD, Powers SW: Case Study: providing evidence-based behavioral and nutrition treatment to a toddler with cystic fibrosis and multiple food allergies via telehealth. Pediatr Pulmonol. 2006 Oct;41(10):1001-4.

Gibson RL, Emerson J, Mayer-Hamblett N, Burns JL, McNamara S, Accurso FJ, Konstan MW, Chatfield BA, Retsch-Bogart G, Waltz DA, Acton J, Zeitlin P, Hiatt P, Moss R, Williams J, Ramsey BW: Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol. 2007 July; 42(7):610-23.

Boesch RP, Acton JD: Outcomes of fundoplication in children with cystic fibrosis. J Pediatr Surg. 2007 Aug; 42(8):1341-4.

Boat, TF, Acton, JD. Cystic Fibrosis. In Nelson Textbook of Pediatrics, 18th edition. Eds. Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Philadelphia: Saunders/Elsevier, 2007.

Sobande PO, Acton JD, Amin RS, Weiland J: Obliterative bronchiolitis in a 13-year-old pre-transplant cystic fibrosis patient. J Cyst Fibros. 2008 Jan;7(1):92-4.

Presentations, Most Recent

Acton, J.D.: Change the Outcome: Lessons Learned from Improving CF Care. Presented at the Advances in Pediatrics Seminar, St. Mary’s Medical Center; August 11, 2005; Evansville, IN.

Acton, J.D.: Is There a Better Way? One Team’s Approach to Benchmarking. Presented at the 19th Annual North American Cystic Fibrosis Conference; October 20-23, 2005; Baltimore, MD.

Acton, J.D.: Improving Healthcare Outcomes: Lessons from the CF Journey. Presented at Interdisciplinary Grand Rounds, Cincinnati Children’s Hospital Medical Center; August 23, 2006; Cincinnati, OH.

Acton, J.D.; Weiland, J.; Cook, K.: Working with Parents to Develop Quality Improvement Programs that Work. Presented at the Pediatric Renal Symposium, Pediatric Renal Group of The Renal Network, Inc.; September 14-15, 2006; Indianapolis, IN.

Acton, J.D.; O’Connor, G.: Accelerating Improvement through Data Transparency and Benchmarking. Symposium Co-Chair at the 20th Annual North American Cystic Fibrosis Conference; November 2-5, 2006; Denver, CO.